# Fluorescence, Light-microscopy, Ultrasound Integrated / Intraoperative Diagnosis to MAXimise Resection

> **NCT05330559** · — · UNKNOWN · sponsor: **Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta** · enrollment: 50 (estimated)

## Conditions studied

- Patients With Radiological, Clinical and Anamnestic Picture Compatible With a New Diagnosis of Glioblastoma

## Interventions

- **OTHER:** Fluid MAX group

## Key facts

- **NCT ID:** NCT05330559
- **Lead sponsor:** Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-08
- **Primary completion:** 2023-04-08
- **Final completion:** 2024-04-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05330559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05330559, "Fluorescence, Light-microscopy, Ultrasound Integrated / Intraoperative Diagnosis to MAXimise Resection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05330559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*